KM
Kumari Mukta Priyadarshni
About Kumari Mukta Priyadarshni
Data last updated:
Kumari Mukta Priyadarshni is a Director at Bitco Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Bitco Pharmaceutical Private Limited reported revenue of ₹43.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bitco Pharmaceutical Private Limited U24230DL2022PTC393713 | Director | 11 Feb 2022 | 2022 | ₹43.2 Lakh (FY 2025) | Active |
Board colleagues of Kumari Mukta Priyadarshni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babli | 10766816 | Bitco Pharmaceutical Private Limited | Director |
| Kusum | 09502180 | Bitco Pharmaceutical Private Limited | Director |
| Rahul Sharma | 10059214 | Bitco Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumari Mukta Priyadarshni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumari Mukta Priyadarshni
Kumari Mukta Priyadarshni currently holds 1 directorship: Bitco Pharmaceutical Private Limited (Director, since 11 Feb 2022, revenue ₹43.2 Lakh (FY 2025)).
Kumari Mukta Priyadarshni was first appointed on 11 Feb 2022 as Director at Bitco Pharmaceutical Private Limited.
The current boards of Kumari Mukta Priyadarshni's companies include Babli (Bitco Pharmaceutical Private Limited), Kusum (Bitco Pharmaceutical Private Limited), Rahul Sharma (Bitco Pharmaceutical Private Limited).